Predictors of Occult Atrial Fibrillation in 171 Patients With Cryptogenic TIA and Minor Stroke

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

171 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-02-28

Study Completion Date

2013-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Retrospective study, single-center, on 171 patients, presented a cryptogenic TIA and Minor stroke.

This study objective is to determine profitability of Holter 21 days for screening paroxystic ACFA / flutter in cryptogenic TIA/Minor stroke, and identify the predictive factors of discovery a paroxystic ACFA on Holter 21 days. Clinical and échocardiographics factors, and brain imaging (scanner and MRI) will be analyzed.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Detection of Occult Paroxysmal Atrial Fibrillation After Stroke Using Prolonged Ambulatory Cardiac Monitoring

NCT01325545

Stroke Atrial Fibrillation

COMPLETED

Extended Rhythm SCreening for AtRial Fibrillation in Cryptogenic Stroke Patients

NCT01550042

Atrial Fibrillation Stroke

TERMINATED

Atrial Fibrillation Detected by ELR and Holter Recording, a Comparison in Patients With Ischemic Stroke or TIA

NCT02155907

Stroke Ischaemic Stroke Atrial Fibrillation +1 more

COMPLETED

Early Detection Of Atrial Fibrillation In Patients With Transient Ischemic Attack

NCT02011256

Transient Ischemic Attack Atrial Fibrillation

COMPLETED NA

30-Day Cardiac Event Monitor Belt for Recording Atrial Fibrillation After a Cerebral Ischemic Event

NCT00846924

Stroke Transient Ischemic Attack Atrial Fibrillation +1 more

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cryptogenic Transient Ischemic Attack and Minor Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients taken care in neurovascular unit

Group Type EXPERIMENTAL

Holter 21 days

Intervention Type PROCEDURE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Holter 21 days

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Cryptogenic TIA/Minor stroke
* Age \> 18 years
* Medical care in Neuro Vascular Unit of CH Versailles
* Holter 21 days performed

Exclusion Criteria

1. ACFA history
2. ECG or telemetry who showed ACFA before the Holter initializing
3. Carotid Stenosis / symptomatic vertebral
4. Arterial dissection
5. Prothrombotic state demonstrated by laboratory tests
6. Infective endocarditis

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No